/
/
/

Sun Pharma Advanced Research Company Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)175.00
Volume (₹)6.61 L
High (₹)183.95
Upper Circuit210.88
Low (₹)173.50
Lower Circuit140.60
Prev Close175.74
52W High (₹)289.00
Price182.10
52W Low (₹)108.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)5711.58 Cr
Div. Yield (%)0.00
PE Ratio3.49
Debt to Equity0.42
Price to Book2.78
Book Value41.25
EPS (TTM)50.41
Face Value1.00
ROE (%)276.89

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
PFOCUSNSE
SAGILITYNSE
IGILNSE
SYNGENENSE
INDGNNSE
HORIZONINDNSE
NESCONSE
SPARCNSE
JUSTDIALNSE
SMARTWORKSNSE
LTP
1W Low
1W High
Market cap (₹)
303.8+15.7 (5.45%)
280.05
304.35
22,561Cr
43.32+1.24 (2.95%)
41.99
44.09
19,821Cr
401.45+3.7 (0.93%)
390.40
411
17,617Cr
408.85+6.15 (1.53%)
404.20
421
16,401Cr
617+30.2 (5.15%)
611
638
14,779Cr
44.22+0.56 (1.28%)
42.51
44.80
12,440Cr
1047.95+56.55 (5.70%)
996
1054.05
7,300Cr
182.1+5.64 (3.20%)
170.61
183.95
5,712Cr
671.5+27 (4.19%)
644.50
681.55
5,653Cr
484+3.5 (0.73%)
468.05
499.85
5,499Cr

Key Highlights of Sun Pharma Advanced Research Company Ltd Balance Sheet

Sun Pharma Advanced Research Company Ltd balance sheet discloses shareholders' funds of ₹32.45Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹32.45Cr, and the reserves and surplus of the company is ₹1301.13Cr.

The company has its non-current liabilities with total liabilities of ₹2167.99Cr as of 2026-03-31.

The current liabilities are ₹756.83Cr as of 2026-03-31. At the same time, current assets are ₹1861.38Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹42.69Lakh and tangible assets of ₹85.32Cr, provided in the Sun Pharma Advanced Research Company Ltd financial statements.